Evidence method
Level · gp.fundamentals.capex_revenue_ratio
24.99% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
OCUL · Jun 30, 2026
OCULAR THERAPEUTIX, INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-089450General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-499.24% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
0.12% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
28.39% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
85.08% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-609.34% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
401.77% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
108.71% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- 43.23%
- Current
- 24.99%
- Delta
- -18.24%
- Previous
- -611.90%
- Current
- -499.24%
- Delta
- 112.66%
- Previous
- 0.81%
- Current
- 0.12%
- Delta
- -0.69%
- Previous
- 34.65%
- Current
- 28.39%
- Delta
- -6.26%
- Previous
- 87.68%
- Current
- 85.08%
- Delta
- -2.60%
- Previous
- -865.46%
- Current
- -609.34%
- Delta
- 256.12%
- Previous
- 613.94%
- Current
- 401.77%
- Delta
- -212.17%
- Previous
- 144.48%
- Current
- 108.71%
- Delta
- -35.77%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · OCULAR THERAPEUTIX, INC →Transitioned To · OCUL Fundamental State →Transitioned To · OCUL CAPEX_INTENSITY_DECREASED →Transitioned To · OCUL CASH_GENERATION_INCREASED →Transitioned To · OCUL GROWTH_DECREASED →Transitioned To · OCUL INVENTORY_PRESSURE_DECREASED →Transitioned To · OCUL MARGIN_DECREASED →Transitioned To · OCUL PROFITABILITY_INCREASED →Transitioned To · OCUL R_AND_D_INTENSITY_DECREASED →Transitioned To · OCUL SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.